|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Costs and expenses: | |||||
| Cost of revenue | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Gain from litigation settlement | |||||
| Impairment of goodwill and long-lived assets | |||||
| Total costs and expenses | |||||
| Loss from operations | |||||
| Gain on extinguishment of debt | |||||
| Interest expense, net | |||||
| Interest (expense) income, net | |||||
| Change in fair value of common stock warrant liabilities | |||||
| Other expense, net of other income | |||||
| Loss before income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Net loss per share attributable to common stockholders: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Other comprehensive loss: | |||||
| Change in unrealized gain on available-for-sale investments, net of tax | |||||
| Foreign currency translation loss | |||||
| Total other comprehensive (loss) income | |||||
| Total comprehensive loss |
Loading...